Articoli con mandati relativi all'accesso pubblico - Victor VelculescuUlteriori informazioni
Non disponibile pubblicamente: 1
Phase I study of rapid alternation of sunitinib and regorafenib for the treatment of tyrosine kinase inhibitor refractory gastrointestinal stromal tumors
C Serrano, A Leal, Y Kuang, JA Morgan, CM Barysauskas, J Phallen, ...
Clinical Cancer Research 25 (24), 7287-7293, 2019
Mandati: US National Institutes of Health, Government of Spain, Dutch Cancer Society
Disponibili pubblicamente: 138
Cancer genome landscapes
B Vogelstein, N Papadopoulos, VE Velculescu, S Zhou, LA Diaz Jr, ...
science 339 (6127), 1546-1558, 2013
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
An integrated genomic analysis of human glioblastoma multiforme
DW Parsons, S Jones, X Zhang, JCH Lin, RJ Leary, P Angenendt, ...
science 321 (5897), 1807-1812, 2008
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
IDH1 and IDH2 Mutations in Gliomas
H Yan, DW Parsons, G Jin, R McLendon, BA Rasheed, W Yuan, I Kos, ...
New England journal of medicine 360 (8), 765-773, 2009
Mandati: US National Institutes of Health
Detection of circulating tumor DNA in early-and late-stage human malignancies
C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ...
Science translational medicine 6 (224), 224ra24-224ra24, 2014
Mandati: US National Institutes of Health, Wellcome Trust, Governo Italiano
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
S Jones, X Zhang, DW Parsons, JCH Lin, RJ Leary, P Angenendt, ...
science 321 (5897), 1801-1806, 2008
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
S Yachida, S Jones, I Bozic, T Antal, R Leary, B Fu, M Kamiyama, ...
Nature 467 (7319), 1114-1117, 2010
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1
N Agrawal, MJ Frederick, CR Pickering, C Bettegowda, K Chang, RJ Li, ...
Science 333 (6046), 1154-1157, 2011
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
Neoadjuvant PD-1 blockade in resectable lung cancer
PM Forde, JE Chaft, KN Smith, V Anagnostou, TR Cottrell, MD Hellmann, ...
New England Journal of Medicine 378 (21), 1976-1986, 2018
Mandati: US National Institutes of Health, LUNGevity Foundation, USA
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Y Jiao, C Shi, BH Edil, RF De Wilde, DS Klimstra, A Maitra, RD Schulick, ...
Science 331 (6021), 1199-1203, 2011
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
PJ Killela, ZJ Reitman, Y Jiao, C Bettegowda, N Agrawal, LA Diaz Jr, ...
Proceedings of the National Academy of Sciences 110 (15), 6021-6026, 2013
Mandati: US National Institutes of Health, Wellcome Trust
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
S Jones, TL Wang, IM Shih, TL Mao, K Nakayama, R Roden, R Glas, ...
Science 330 (6001), 228-231, 2010
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
AACR Project GENIE: powering precision medicine through an international consortium
AACR Project Genie Consortium, AACR Project GENIE Consortium, ...
Cancer discovery 7 (8), 818-831, 2017
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, Dutch …
Direct detection of early-stage cancers using circulating tumor DNA
J Phallen, M Sausen, V Adleff, A Leal, C Hruban, J White, V Anagnostou, ...
Science translational medicine 9 (403), eaan2415, 2017
Mandati: US National Institutes of Health, Danish Council for Independent Research …
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
J Yun, C Rago, I Cheong, R Pagliarini, P Angenendt, H Rajagopalan, ...
Science 325 (5947), 1555-1559, 2009
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
S Jones, RH Hruban, M Kamiyama, M Borges, X Zhang, DW Parsons, ...
Science 324 (5924), 217-217, 2009
Mandati: US National Institutes of Health
Genome-wide cell-free DNA fragmentation in patients with cancer
S Cristiano, A Leal, J Phallen, J Fiksel, V Adleff, DC Bruhm, SØ Jensen, ...
Nature 570 (7761), 385-389, 2019
Mandati: US National Institutes of Health, Danish Council for Independent Research …
Comparative lesion sequencing provides insights into tumor evolution
S Jones, W Chen, G Parmigiani, F Diehl, N Beerenwinkel, T Antal, ...
Proceedings of the National Academy of Sciences 105 (11), 4283-4288, 2008
Mandati: Howard Hughes Medical Institute
Evolution of neoantigen landscape during immune checkpoint blockade in non–small cell lung cancer
V Anagnostou, KN Smith, PM Forde, N Niknafs, R Bhattacharya, J White, ...
Cancer discovery 7 (3), 264-276, 2017
Mandati: US National Institutes of Health, Dutch Cancer Society, LUNGevity Foundation …
Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing
RJ Leary, M Sausen, I Kinde, N Papadopoulos, JD Carpten, D Craig, ...
Science translational medicine 4 (162), 162ra154-162ra154, 2012
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software